Corrigendum to "Clinical implications of body mass index (BMI) and weight in metastatic breast cancer (BC) patients treated with abemaciclib and endocrine therapy: A pooled individual patient level data analysis of MONARCH 2 and MONARCH 3 trials": Annals of Oncology 2020; volume 31, supplement 2; s71 (abstr. 153P)

MLA

Franzoi, M. A., et al. “Corrigendum to ‘Clinical Implications of Body Mass Index (BMI) and Weight in Metastatic Breast Cancer (BC) Patients Treated with Abemaciclib and Endocrine Therapy: A Pooled Individual Patient Level Data Analysis of MONARCH 2 and MONARCH 3 Trials’: Annals of Oncology 2020; Volume 31, Supplement 2; S71 (Abstr. 153P).” Annals of Oncology, vol. 31, no. 10, Oct. 2020, p. 1423. EBSCOhost, https://doi.org/10.1016/j.annonc.2020.07.018.

APA

Franzoi, M. A., Ameye, L., Eiger, D., Piccart, M., Brandão, M. D. R. A., Pondé, N., Desmedt, C., Di Cosimo, S., Paesmans, M., Caparica, R., Kotecki, N., Lambertini, M., De Angelis, C., Awada, A. H., & de Azambuja, E. (2020). Corrigendum to “Clinical implications of body mass index (BMI) and weight in metastatic breast cancer (BC) patients treated with abemaciclib and endocrine therapy: A pooled individual patient level data analysis of MONARCH 2 and MONARCH 3 trials”: Annals of Oncology 2020; volume 31, supplement 2; s71 (abstr. 153P). Annals of Oncology, 31(10), 1423. https://doi.org/10.1016/j.annonc.2020.07.018

Chicago

Franzoi, M.A., L. Ameye, D. Eiger, M. Piccart, M.D.R.A. Brandão, N. Pondé, C. Desmedt, et al. 2020. “Corrigendum to ‘Clinical Implications of Body Mass Index (BMI) and Weight in Metastatic Breast Cancer (BC) Patients Treated with Abemaciclib and Endocrine Therapy: A Pooled Individual Patient Level Data Analysis of MONARCH 2 and MONARCH 3 Trials’: Annals of Oncology 2020; Volume 31, Supplement 2; S71 (Abstr. 153P).” Annals of Oncology 31 (10): 1423. doi:10.1016/j.annonc.2020.07.018.